MCT1 inhibition atan AZD3965 dose of 1.1 mg/kg clearly decreased tumor uptake from 60.8± 22.8 PSL/mm2 (nonblocking group) to 15.2 ±5.5 PSL/mm2 (MCT1 blocking group, n =4) with a P < 0.001. This evidence concerns the gene SLC16A1 and neoplasm.